Home » Stocks » Personalis

Personalis, Inc. (PSNL)

Stock Price: $14.21 USD 0.57 (4.18%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 450.61M
Revenue (ttm) 70.29M
Net Income (ttm) -28.54M
Shares Out 31.71M
EPS (ttm) -2.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $14.21
Previous Close $13.64
Change ($) 0.57
Change (%) 4.18%
Day's Open 13.81
Day's Range 13.52 - 14.57
Day's Volume 263,532
52-Week Range 4.27 - 25.64

More Stats

Market Cap 450.61M
Enterprise Value 330.57M
Earnings Date (est) Aug 18, 2020
Ex-Dividend Date n/a
Shares Outstanding 31.71M
Float 16.37M
EPS (basic) -1.44
EPS (diluted) -2.00
FCF / Share -1.09
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 841,092
Short Ratio 2.59
Short % of Float 4.32%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 6.41
PB Ratio 4.41
Revenue 70.29M
Operating Income -26.61M
Net Income -28.54M
Free Cash Flow -34.28M
Net Cash 120.03M
Net Cash / Share 3.79
Gross Margin 31.41%
Operating Margin -37.86%
Profit Margin -40.60%
FCF Margin -48.76%
ROA -15.88%
ROE -73.10%
ROIC -90.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 3
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(24.35% upside)
Current: 14.21
Target: 17.67
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth72.62%302.15%-
Gross Profit22.0811.81-2.34
Operating Income-22.42-13.77-22.16
Net Income-25.08-19.89-23.60
Shares Outstanding18.013.063.03
Earnings Per Share-1.39-6.49-7.78
Operating Cash Flow-18.075.570.29
Capital Expenditures-8.38-7.85-5.16
Free Cash Flow-26.45-2.28-4.87
Cash & Equivalents12819.7422.62
Total Debt-5.0017.51
Net Cash / Debt12814.755.11
Book Value107-106-92.60
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Personalis, Inc.
Country United States
Employees 181
CEO John S. West

Stock Information

Ticker Symbol PSNL
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: PSNL


Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves biopharmaceutical customers, universities and non-profits, diagnostics companies, and government entities. Personalis, Inc. has partnership with Berry Genomics. The company was founded in 2011 and is headquartered in Menlo Park, California.